Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a rare tumor, with an increasing incidence worldwide and an overall poor prognosis. Symptoms are usually nonspecific, contributing to an advanced tumor stage at diagnosis. The…
Intrahepatic cholangiocarcinoma (ICC) is a rare tumor, with an increasing incidence worldwide and an overall poor prognosis. Symptoms are usually nonspecific, contributing to an advanced tumor stage at diagnosis. The…
Advances in percutaneous and endoscopic techniques have improved preoperative selection and optimization in patients with biliary and liver tumors, but are not without their own controversies. Selective rather than routine…
Cross-sectional imaging can be useful in the diagnosis of biliary tract and primary liver tumors. Hepatobiliary tumors are diverse in growth patterns, histologic types and tumor location. A fundamental understanding…
Primary liver and biliary tract tumors encompass a range of benign and malignant neoplasms. They consist of histologically distinct types of tumors that arise from and are influenced by hepatocytes,…
Timothy M. Pawlik, MD, MPH, PhD, Editor This issue of the Surgical Oncology Clinics of North America brings together experts in the field of biliary tract and primary liver tumors….
Evidence has shown that multidisciplinary specialist team evaluation and management for cancer results in better patient outcomes. For breast cancer, breast centers are where this evaluation and management occurs. The…
The surgical management of breast cancer has evolved significantly, facilitated by advancements in technology and imaging and improvements in adjuvant therapy. The changes in surgical management have been characterized by…
African American women have a lower lifetime incidence of breast cancer than white/Caucasian Americans yet have a higher risk of breast cancer mortality. African American women are also more likely…
The guiding principles of nipple-sparing mastectomy (complete removal of the breast from its skin and reconstructing without changing the appearance of the breast) are based on patient safety followed by…
Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/ neu protein markers. This basic feature is clinically relevant because it indicates…